Evidence map›Paper›PMID 34683670›Full record

ArticleMaterials (Basel, Switzerland)2021

Porous Ultrahigh Molecular Weight Polyethylene/Functionalized Activated Nanocarbon Composites with Improved Biocompatibility.

Wangxi Fan, Xiuqin Fu, Zefang Li, Junfei Ou, Zhou Yang, Meng Xiang, Zhongli Qin

Abstract read
In one paragraph

Article in Materials (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Wangxi FanSchool of Materials Engineering, Jiangsu University of Technology, Changzhou 213001, China.ORCID 0000-0003-2125-5785
Xiuqin FuSchool of Life Science and Technology, Wuhan Bioengineering Institute, Wuhan 430415, China.
Zefang LiSchool of Computer Engineering, Jiangsu University of Technology, Changzhou 213001, China.
Junfei OuSchool of Materials Engineering, Jiangsu University of Technology, Changzhou 213001, China.
Zhou YangSchool of Materials Engineering, Jiangsu University of Technology, Changzhou 213001, China.ORCID 0000-0001-8424-1933
Meng XiangSchool of Materials Engineering, Jiangsu University of Technology, Changzhou 213001, China.
Zhongli QinSchool of Electronics and Information Engineering, Hubei University of Science and Technology, Xianning 437100, China.

Funding

Youth Science Foundation of Jiangsu University of Technology KYY19031
6 · The paper itself

Abstract

Ultrahigh molecular weight polyethylene (UHMWPE) materials have been prevalent joint replacement materials for more than 45 years because of their excellent biocompatibility and wear resistance. In this study, functionalized activated nanocarbon (FANC) was prepared by grafting maleic anhydride polyethylene onto acid-treated activated nanocarbon. A novel porous UHMWPE composite was prepared by incorporating the appropriate amount of FANC and pore-forming agents during the hot-pressing process for medical UHMWPE powder. The experimental results showed that the best prepared porous UHMWPE/FANC exhibited appropriate tensile strength, porosity, and excellent hydrophilicity, with a contact angle of 65.9°. In vitro experiments showed that the porous UHMWPE/FANC had excellent biocompatibility, which is due to its porous structure and hydrophilicity caused by FANC. This study demonstrates the potential viability for our porous UHMWPE/FANC to be used as cartilage replacement material for biomedical applications.

Indexed as

activated nanocarbonbiocompatibility in vitrohydrophilicityporous materials

Identifiers

PMID34683670
PMCPMC8541245

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.